
🚨 New preprint! 🚨 We reveal that blaTEM-1 expression varies across the E. coli phylogeny, driving differences in co-amoxiclav resistance: biorxiv.org/content/10.1101/…

wellcome early-career award fellow @milnercentre | formerly @oxfordbiology and @modmedmicro

🚨 New preprint! 🚨 We reveal that blaTEM-1 expression varies across the E. coli phylogeny, driving differences in co-amoxiclav resistance: biorxiv.org/content/10.1101/…

Today my first editorial article came out! It's both an intro to my Monash Bioethics Review special issue on antimicrobial stewardship and social justice, and also an original article examining issues with the precautionary principle as a justification. link.springer.com/article/10…

Finally out after peer review, our update on the integron model showing that translation rates of cassettes in first position influence the phenotypes conferred by others downstream. Great effort by @AndrePCarvalho nature.com/articles/s41467-0…

So exciting to see our (Liam Shaw, @Sheppard_Lab, @EpicFeil_) piece on the current state of plasmid epidemiology is now out: microbiologyresearch.org/con… @NDMOxford @OxfordBiology @IneosOxford @MilnerCentre

Thanks for reading and let me know if you have any questions! (10/10)

2) How can we routinely incorporate phylogenetic information into AMR phenotype prediction? Hybrid assemblies are not always possible, so we need shortcuts. (9/10)

1) Why is there variability? I think studies like this will help us find the answer: biorxiv.org/content/10.1101/… (8/10)

So it seems that phylogenetic context is indeed relevant. Going forward, there are two avenues of investigation… (7/10)

Next, and crucially, does this variability in expression drive variability in MIC (again, controlling for the factors we can readily annotate or calculate)? Yes! (6/10)

Yes! And what’s more, some clinically relevant strains seemed to be intrinsically “better” at expressing the AMR gene than some less clinically relevant strains. (5/10)

I wanted to start simple. If I control for all the known factors influencing the expression of my AMR gene, is there still variation across the phylogeny? (4/10)

But what about “The Uncatalogable”, like other regulatory, epistatic, and epigenetic factors? Perhaps these are important, but it’s hard to know where to begin. (3/10)

Say I sample a plasmid spreading an AMR gene around a hospital. Some strains are highly resistant, some less so. Then, I might annotate for known risk factors, like promoter mutations and efflux pumps. I might also look for gene duplications and estimate the copy number. (2/10)

A thread on our study… (1/10)
🚨 New preprint! 🚨 We reveal that blaTEM-1 expression varies across the E. coli phylogeny, driving differences in co-amoxiclav resistance: biorxiv.org/content/10.1101/…

E. coli phylogeny drives co-amoxiclav resistance through variable expression of blaTEM-1 biorxiv.org/cgi/content/shor… #biorxiv_micrbio

Ever wondered how fast accessory genome dynamics of bacteria really is? In a new preprint we (@mrcmolari, Liam Shaw) explore how rapidly E coli picks up genes horizontally, breaks genome synteny, etc.. biorxiv.org/content/10.1101/… For a thread by Marco see mstdn.science/@mrcmlr/112772…